The FDA has extended approval of the MiniMed 670G hybrid closed-loop system to younger individuals aged 7 to 13 years with type 1 diabetes. As previously reported by Endocrine Today, the closed-loop ...

Compared with standard care, a closed-loop insulin delivery system increased the time spent within the pregnancy-specific glucose target range between 16 and 34 weeks 6 days ’ gestation among pregnant ...